Several effectors of angiogenesis, VEGFA-VEGFR2, IGF1 [207,208,209,210,211,338], and the Ras signaling pathway [345,346,370,371], are all downregulated in cerebral endothelial cells of AD patients. This evidence concerns the gene VEGFA and Alzheimer disease.